Status:

TERMINATED

Study of the Safety and Tolerability of AXA1957 in Adolescent Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)

Lead Sponsor:

Axcella Health, Inc

Conditions:

NAFLD

Eligibility:

All Genders

12-17 years

Phase:

NA

Brief Summary

This is a randomized, single blind study to determine whether AXA1957, a novel composition of amino acids, is safe and well tolerated. Subjects will be adolescents with non-alcoholic fatty liver disea...

Eligibility Criteria

Inclusion

  • Key
  • Willing to participate in the study and provide written informed consent.
  • Male and female adolescent subjects aged 12 to 17 years
  • Subjects must not have participated in any diet/lifestyle intervention or observational studies, or engaged in any body weight altering regimens that resulted in body weight fluctuations (i.e. body weight loss or gain by 5%) in the preceding 30 days prior to Screening.
  • Non alcoholic fatty liver disease
  • Diabetes or prediabetes
  • A screening MRI consistent with liver inflammation and fibrosis
  • Key

Exclusion

  • Current or history of significant alcohol consumption
  • History or presence of liver disease (other than NAFLD/NASH)
  • History or presence of cirrhosis and/or history or presence of hepatic decompensation
  • Any diabetes other than Type 2
  • Other poorly controlled medical condition (for example, uncontrolled hypertension with a systolic blood pressure \> 100 mmHg)
  • Known sensitivity and/or history of clinically significant food intolerance/allergies to proteins (including whey, soy, casein, amino acids, etc.),
  • Unable or unwilling to adhere to contraception requirements
  • Any contraindications to a MRI scan
  • Any other condition that, in the opinion of the Investigator, renders the subject at risk for compliance, compromises the well-being of the subject, or hinders study completion

Key Trial Info

Start Date :

July 27 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2020

Estimated Enrollment :

9 Patients enrolled

Trial Details

Trial ID

NCT04073407

Start Date

July 27 2019

End Date

September 1 2020

Last Update

September 23 2021

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Royal London Children's Hospital

London, United Kingdom, E1 1BB

2

King's College Hospital

London, United Kingdom

3

Royal Manchester Children's Hospital

Manchester, United Kingdom

4

Univeristy of Southhampton

Southampton, United Kingdom, S016 6YD